Understanding Components of Mind-body Exercise for Physical Activity Engagement in Metabolic Syndrome
1 other identifier
interventional
34
1 country
1
Brief Summary
The aim of this study is to assess the feasibility and acceptability (e.g., enrollment, adherence, retention, acceptability of procedures and interventions) of a pilot factorial study design that will help elucidate components of mind-body exercise interventions. The study involves completing a walking program, a mindful attention program, a walking program that includes mindful attention, or no program at all. A "pilot" study is a smaller study that helps researchers to understand whether the study design can be carried out and what participants think about the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2022
CompletedFirst Posted
Study publicly available on registry
February 16, 2022
CompletedStudy Start
First participant enrolled
January 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2026
CompletedApril 20, 2026
April 1, 2026
3.1 years
January 27, 2022
April 17, 2026
Conditions
Outcome Measures
Primary Outcomes (8)
Feasibility of screening: screened to eligible ratio
percent of screened individuals that were determined eligible for the study
Through study completion, an average of 1 year
Feasibility of enrollment: eligible to enrollment ratio
percent of eligible individuals that enroll in the study; determined to be feasible if greater than or equal to 70% of eligible patients enroll
Through study completion, an average of 1 year
Feasibility of retention: retention at each assessment
percent of enrolled participants retained at post-intervention and 3-month follow-up; determined to be feasible if greater than or equal to 70% retention at each assessment
6 months
Feasibility of interventions: attendance rates for each session
percent session attendance; determined to be feasible if participants attend greater than or equal to 75% of sessions
6 months
Feasibility of survey completion: survey completion rates at each assessment
percent of participants that complete surveys at post-intervention and 3-month follow-up
6 months
Acceptability of interventions
Acceptability of the interventions will be assessed via overall satisfaction (1 = not at all to 10 = very much); determined to be acceptable if mean rating is greater than or equal to 7.5 across 80% of sessions
6 months
Acceptability of study design
Acceptability of the study design will be assessed via acceptability of study procedures (1= not at all to 10 = very much); determined to be acceptable if mean rating is greater than or equal to 7.5 across 80% of sessions
6 months
Perspectives on study interventions
Perspectives on study interventions will be assessed via exit interview
Post-intervention (after 8 week intervention)
Secondary Outcomes (12)
Ventilatory efficiency
Baseline (week 0), post-intervention (after 8 week intervention)
Heart rate dynamics
Baseline (week 0), post-intervention (after 8 week intervention)
Positive affect
Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention
Emotion regulation
Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention
Interoceptive awareness
Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention
- +7 more secondary outcomes
Study Arms (4)
Mindful attention
EXPERIMENTAL16 sessions over 8 weeks (2x/week) of mindful attention audio recordings delivered via headphones
Exercise
EXPERIMENTAL16 sessions over 8 weeks (2x/week) of moderate-intensity treadmill walking
Exercise with mindful attention
EXPERIMENTAL16 sessions over 8 weeks (2x/week) of moderate-intensity treadmill walking utilizing mindful attention audio recordings delivered via headphones
No intervention
NO INTERVENTIONNo intervention sessions
Interventions
Participants will listen to mindful attention audio recordings via headphones
Participants will complete a moderate-intensity walking program while listening to mindful attention audio recordings via headphones
Eligibility Criteria
You may qualify if:
- Metabolic syndrome, defined as meeting 3 or more of the following criteria in the last 12 months at the time of medical record review: (a) BMI ≥ 25; (b) fasting glucose ≥ 100 \[5.6 mmol/L\] or A1C ≥ 5.7 or medications; (c) blood pressure ≥ 130 systolic or ≥ 85 diastolic or medications; (d) triglycerides ≥ 150 or 1.7 mmol/L or medications; (e) or HDL \< 40mg/ dL for men and 50mg/dL for women or medications;
- insufficiently active, defined as a score ≤ 23 (moderate-to-strenuous units) on Godin-Shepard Leisure-Time Physical Activity Questionnaire;
- age 18-70 years;
- given medical clearance for moderate-intensity exercise and exercise stress testing by their primary care physician (PCP);
- access to a device with internet and videoconferencing capabilities
You may not qualify if:
- current diagnosis of any of the following: (a) coronary artery disease or other chronic heart diseases (e.g., heart failure) in which exercise would be contraindicated or that would preclude HRV analyses (e.g., some arrhythmias); (b) any diabetes; (c) chronic obstructive pulmonary disease or other severe lung dysfunction (e.g., severe asthma); (d) severe cognitive impairment
- \>2 self-reported classes or self-guided mindfulness or mindful movement sessions per week in past 3 months
- self-reported inability to speak and read in English
- current beta blocker or calcium channel blocker medication
- uncontrolled hypertension, defined as resting blood pressure ≥ 150 systolic or ≥ 90 diastolic in the last 6 months
- self- or physician-reported contraindications for exercise (e.g., severe balance impairment, musculoskeletal restrictions)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor of Medicine
Study Record Dates
First Submitted
January 27, 2022
First Posted
February 16, 2022
Study Start
January 31, 2023
Primary Completion
March 9, 2026
Study Completion
March 9, 2026
Last Updated
April 20, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share